How to buy McKesson Corporation shares

Own McKesson Corporation shares in just a few minutes. Share price changes are updated daily.

Fact checked

McKesson Corporation (MCK) is a leading medical distribution business based in the US. McKesson Corporation is listed on the NYSE and employs 60,000 staff. All prices are listed in US Dollars.

How to buy shares in McKesson Corporation

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: MCK in this case.
  5. Research McKesson Corporation shares. The platform should provide the latest information available.
  6. Buy your McKesson Corporation shares. It's that simple.
The whole process can take as little as 15 minutes.

McKesson Corporation share price

Use our graph to track the performance of MCK stocks over time.

McKesson Corporation shares at a glance

Information last updated 2021-01-23.
52-week range$111.7378 - $187.2321
50-day moving average $177.5779
200-day moving average $161.6399
Wall St. target price$204.5
PE ratio 14.1977
Dividend yield $1.68 (0.91%)
Earnings per share (TTM) $13.031
Promoted
eToro Free Stocks

Invest in McKesson Corporation shares with 0% commission

Other fees may apply. Your capital is at risk.

  • Unlimited trades, with no dealing charges or management fees
  • If your trades get copied you can earn extra money
  • Create an account today in a few minutes

Share dealing platform comparison

Table: sorted by promoted deals first
Data indicated here is updated regularly
Name Product Price per trade Frequent trader rate Platform fees Brand description
Fineco
£2.95
£2.95
Zero platform fee
Your first 100 trades are free with Fineco, T&Cs apply.
Fineco Bank is good for share traders and investors looking for a complete platform and wide offer. Capital at risk.
eToro Free Stocks
0% commission, no markup, no ticket fee, no management fee
N/A
Withdrawal fee & GDP to USD deposit conversion
Capital at risk. 0% commission but other fees may apply.
Stake
£0
£0
Zero platform fee
Join and receive a free share worth up to £100
Access unlimited commission-free trading on 3,800+ US stocks and ETFs with Stake. Capital at risk.
IG
0% commission on US shares, and £3 on UK shares
From £5
£0 - £24 per quarter
IG is good for experienced traders, and offers learning resources for beginners, all with wide access to shares, ETFs and funds. Capital at risk.
Degiro Share Dealing
£1.75 + 0.022% (max £5.00)
£1.75 + 0.022% (max £5.00)
Portfolio transfer fees (in & out)
Degiro is widely seen as one of the best low-cost share brokers, for people who are looking to trade regularly. Capital at risk.
Hargreaves Lansdown Fund and Share Account
£11.95
£5.95
No fees
Hargreaves Lansdown is the UK's number one platform for private investors, with the depth of features you'd expect from an established platform. Capital at risk.
Interactive Investor
From £7.99 on the Investor Service Plan
From £7.99 on the Investor Service Plan
No transfer fees or exit fees. £9.99 a month on the Investor Service Plan
Open an ISA, Trading Account or SIPP you will get £100 of free trades to buy or sell any investment (new customers only).
Interactive Investor offers everything most investors need. Its flat fees makes it pricey for small portfolios, but cheap for big ones. Capital at risk.
loading

Compare up to 4 providers

Data indicated here is updated regularly
Name Product Minimum deposit Maximum annual fee Price per trade Brand description
Interactive Investor stocks and shares ISA
Any lump sum or £25 a month
£119.88
£7.99
Interactive Investor offers everything most investors need. Its flat fees makes it pricey for small portfolios, but cheap for big ones. Capital at risk.
Moneyfarm stocks and shares ISA
£1500
0.75%
£0
Moneyfarm helps you meet your investment goals with fully-managed portfolios designed around you. Capital at risk.
Hargreaves Lansdown stocks and shares ISA
£100
0.45%
£11.95
Hargreaves Lansdown is the UK's biggest wealth manager. It's got everything you'll need, from beginners to experienced investors. Capital at risk.
Nutmeg stocks and shares ISA
£100
0.75%
£0
Nutmeg offers three types of portfolios. Choose the one that goes with your investment style. Capital at risk.
Saxo Markets stocks and shares ISA
No minimum deposit requirement
0.12%
£8.00
Saxo Markets offers a wide access to a range of stocks, ETFs and funds. Capital at risk.
AJ Bell stocks and shares ISA
£500
0.25%
£9.95
AJ Bell is a good all-rounder for people who to choose between shares, funds, ISAs and pensions. Capital at risk.
Fidelity stocks and shares ISA
£1000 or a regular savings plan from £50
0.35%
£10.00
Fidelity is another good all-rounder, offering a good package at a decent price. Not suited for trading shares. Capital at risk.
Legal & General stocks and shares ISA
Legal & General stocks and shares ISA
£100 or £20 a month
0.61%
N/A
Legal & General is a big financial services company which offers insurance, lifetime mortgage, pensions and stocks and shares ISAs. Capital at risk.
loading

Compare up to 4 providers

Data indicated here is updated regularly
Name Product Minimum investment Choose from Annual fee Brand description
Interactive Investor Pension
Any lump sum or £25 a month
Over 3,000 funds
£10/month
interactive investor is a flat-fee platform, which makes it cost effective for larger portfolios. Capital at risk.
Moneyfarm Pension
£1,500 (initial investment)
7 funds
0.35%-0.75%
Moneyfarm has pensions that are matched against your risk appetite, goals and planned retirement date. Capital at risk.
AJ Bell Pension
£1,000
Over 2,000 funds
0.05-0.25%
AJ Bell has two different pension options, a self managed pension and one that is managed for you. Capital at risk.
PensionBee Pension
No minimum
7 funds
0.5% - 0.95%
Pension Bee is a newbie in the pension market. It helps consolidate your pension plans into one place. Capital at risk.
Hargreaves Lansdown Pension
£100 or £25 a month
2,500 funds
0-0.45%
Hargreaves Lansdown is the UK's biggest wealth manager. It's got three different retirement options. Capital at risk.
Saxo Markets Pension
Saxo Markets Pension
£10
Over 11,000 funds
No annual fee
Saxo Markets gives flexibility and control over your investment strategy. Capital at risk.
Penfold
Penfold
No minimum
4 portfolios
0.75-0.88%
Moneybox Pension
£1
3 funds
0.15% - 0.45% charged monthly
Manage your money with an easy-to-use Moneybox app. Capital at risk.
loading

Compare up to 4 providers

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is it a good time to buy McKesson Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Is McKesson Corporation under- or over-valued?

Valuing McKesson Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of McKesson Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

McKesson Corporation's P/E ratio

McKesson Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 14x. In other words, McKesson Corporation shares trade at around 14x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

McKesson Corporation's PEG ratio

McKesson Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 26.752. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into McKesson Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

McKesson Corporation's EBITDA

McKesson Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is a whopping $3.8 billion.

The EBITDA is a measure of a McKesson Corporation's overall financial performance and is widely used to measure a its profitability.

McKesson Corporation financials

Revenue TTM $234.2 billion
Operating margin TTM 1.25%
Gross profit TTM $12 billion
Return on assets TTM 3.03%
Return on equity TTM 31.64%
Profit margin 0.95%
Book value $36.683
Market capitalisation $29.7 billion

TTM: trailing 12 months

How to short and sell McKesson Corporation shares

  1. Create a CFD or spread betting account.
  2. Search for the stock code. E.g. "MCK.US"
  3. Choose your position size.
  4. Select "sell" rather than "buy".
  5. Confirm your position and keep tabs on it. You may wish to set limits on your position.

There are currently 1.2 million McKesson Corporation shares held short by investors – that's known as McKesson Corporation's "short interest". This figure is 16.3% down from 1.4 million last month.

There are a few different ways that this level of interest in shorting McKesson Corporation shares can be evaluated.

McKesson Corporation's "short interest ratio" (SIR)

McKesson Corporation's "short interest ratio" (SIR) is the quantity of McKesson Corporation shares currently shorted divided by the average quantity of McKesson Corporation shares traded daily (recently around 924519.23076923). McKesson Corporation's SIR currently stands at 1.3. In other words for every 100,000 McKesson Corporation shares traded daily on the market, roughly 1300 shares are currently held short.

However McKesson Corporation's short interest can also be evaluated against the total number of McKesson Corporation shares, or, against the total number of tradable McKesson Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case McKesson Corporation's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 McKesson Corporation shares in existence, roughly 10 shares are currently held short) or 0.0075% of the tradable shares (for every 100,000 tradable McKesson Corporation shares, roughly 8 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against McKesson Corporation.

Find out more about how you can short McKesson Corporation stock.

McKesson Corporation's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like McKesson Corporation.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

McKesson Corporation's total ESG risk score

Total ESG risk: 23.8

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and McKesson Corporation's overall score of 23.8 (as at 01/01/2019) is pretty good – landing it in it in the 26th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like McKesson Corporation is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

McKesson Corporation's environmental score

Environmental score: 9.12/100

McKesson Corporation's environmental score of 9.12 puts it squarely in the 8th percentile of companies rated in the same sector. This could suggest that McKesson Corporation is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

McKesson Corporation's social score

Social score: 17.15/100

McKesson Corporation's social score of 17.15 puts it squarely in the 8th percentile of companies rated in the same sector. This could suggest that McKesson Corporation is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

McKesson Corporation's governance score

Governance score: 12.53/100

McKesson Corporation's governance score puts it squarely in the 8th percentile of companies rated in the same sector. That could suggest that McKesson Corporation is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

McKesson Corporation's controversy score

Controversy score: 4/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. A high-profile company, McKesson Corporation scored a 4 out of 5 for controversy – the second-lowest score possible, reflecting that McKesson Corporation has a damaged public profile.

Environmental, social, and governance (ESG) summary

McKesson Corporation was last rated for ESG on: 2019-01-01.

Total ESG score 23.8
Total ESG percentile 26.02
Environmental score 9.12
Environmental score percentile 8
Social score 17.15
Social score percentile 8
Governance score 12.53
Governance score percentile 8
Level of controversy 4

McKesson Corporation share dividends

11%

Dividend payout ratio: 10.61% of net profits

Recently McKesson Corporation has paid out, on average, around 10.61% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.91% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), McKesson Corporation shareholders could enjoy a 0.91% return on their shares, in the form of dividend payments. In McKesson Corporation's case, that would currently equate to about $1.68 per share.

While McKesson Corporation's payout ratio might seem low, this can signify that McKesson Corporation is investing more in its future growth.

McKesson Corporation's most recent dividend payout was on 4 January 2021. The latest dividend was paid out to all shareholders who bought their shares by 30 November 2020 (the "ex-dividend date").

Have McKesson Corporation's shares ever split?

McKesson Corporation's shares were split on a 2:1 basis on 5 January 1998. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your McKesson Corporation shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for McKesson Corporation shares which in turn could have impacted McKesson Corporation's share price.

McKesson Corporation share price volatility

Over the last 12 months, McKesson Corporation's shares have ranged in value from as little as $111.7378 up to $187.2321. A popular way to gauge a stock's volatility is its "beta".

MCK.US volatility(beta: 0.94)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while McKesson Corporation's is 0.9364. This would suggest that McKesson Corporation's shares are less volatile than average (for this exchange).

Win £500 to get your trading started

Subscribe to trending stock alerts for a chance to win

By submitting, you agree to the Finder Privacy and Cookies Policy and Terms of Use

McKesson Corporation overview

McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions, International, and Medical-Surgical Solutions. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and solutions for life sciences companies, including offering multiple distribution channels and clinical trial access to specific patient populations through its network of oncology physicians. The segment also sells financial, operational and clinical solutions to pharmacies; and offers consulting, outsourcing, and other services. The Prescription Technology Solutions segment operates in the healthcare delivery system to connect pharmacies, providers, payers, and biopharma for next-generation patient access and adherence solutions. The International segment provides drug distribution services, specialty pharmacy, and retail and infusion care services. The Medical-Surgical Solutions segment distributes medical-surgical supplies and provides logistics and other services to healthcare providers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Frequently asked questions

More guides on Finder

  • How to buy Transportation and Logistics Systems shares

    Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.

  • How to buy Charlie’s Holdings shares

    Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.

  • How to buy Lemonade shares

    Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.

  • How to buy Unity Software shares

    Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor

  • How to buy FuelCell Energy shares

    Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.

  • How to buy CloudCommerce shares

    Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor

  • How to buy Zomedica Pharmaceuticals shares

    Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.

  • How to buy YRC Worldwide shares

    Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.

  • How to buy Xeros Technology Group shares

    Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.

  • How to buy Xpediator shares

    Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site